Dashboard
Manage Tickers

NKGN NKGen Biotech, Inc.

Nasdaq nkgenbiotech.com


$ -0.01 (-45 %)    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 590.78 $ 0.00 (0 %)
DIA $ 454.80 $ 0.00 (0 %)
SPY $ 651.92 $ 0.00 (0 %)
TLT $ 91.59 $ 0.00 (0 %)
GLD $ 398.68 $ 0.00 (0 %)
$ 0.011
-- x --
-- x --
-- - --
$ 0.00 - $ 0.96
12,451
na
1.37M
$ 0.39
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 10-07-2025 12-31-2024 10-K
2 03-04-2025 01-01-1970 10-Q
3 09-12-2024 06-30-2024 10-Q
4 05-20-2024 03-31-2024 10-Q
5 04-16-2024 12-31-2023 10-K
6 11-14-2023 09-30-2023 10-Q
7 08-14-2023 06-30-2023 10-Q
8 05-15-2023 03-31-2023 10-Q
9 03-31-2023 12-31-2022 10-K
10 11-14-2022 09-30-2022 10-Q
11 08-15-2022 06-30-2022 10-Q
12 05-16-2022 03-31-2022 10-Q
13 03-31-2022 12-31-2021 10-K
14 11-15-2021 09-30-2021 10-Q
15 08-16-2021 06-30-2021 10-Q
16 07-02-2021 03-31-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

nkgen-biotech-receives-fda-expanded-access-approval-to-treat-multiple-neurodegenerative-diseases-with-troculeucel
NKGen Biotech Receives FDA Expanded Access...
07/21/2025 12:16:22

Troculeucel, a cryopreserved, autologous enhanced natural killer cell therapy, has demonstrated preliminary clinical benefit wi...

nkgen-biotech-announces-chairman--ceo-paul-y-song-md-personally-invests-265m-cash-to-accelerate-phase-2-clinical-trial-and-fulfill-financial-reporting-obligations
NKGen Biotech Announces Chairman & CEO Pau...
05/08/2025 12:16:32

New funding from Dr. Song augments $3.0 million in funding advances from AlpineBrook Capital in 2025 above and beyond the $5.5 ...

nkgen-biotech-announces-the-administration-of-troculeucel-to-a-stroke-patient-under-compassionate-use-program
NKGen Biotech Announces The Administration...
03/03/2025 13:01:20

nkgen-biotech-announces-administration-of-autologous-nk-cell-therapy-in-ftd-patient-under-fda-cleared-ind
NKGen Biotech Announces Administration Of ...
02/21/2025 13:05:56

12-health-care-stocks-moving-in-fridays-pre-market-session
12 Health Care Stocks Moving In Friday's P...
02/14/2025 21:05:48

12-health-care-stocks-moving-in-fridays-pre-market-session
12 Health Care Stocks Moving In Friday's P...
02/14/2025 12:05:40

12-health-care-stocks-moving-in-thursdays-pre-market-session
12 Health Care Stocks Moving In Thursday's...
02/13/2025 21:05:47

nkgen-biotech-announces-publication-of-initial-dose-escalation-phase-1-trial-in-the-journal-alzheimers-research--therapy
NKGen Biotech Announces Publication Of Ini...
02/13/2025 13:22:05

12-health-care-stocks-moving-in-thursdays-pre-market-session
12 Health Care Stocks Moving In Thursday's...
02/13/2025 12:05:38

why-applovin-shares-are-trading-higher-by-around-29-here-are-20-stocks-moving-premarket
Why AppLovin Shares Are Trading Higher By ...
02/13/2025 10:20:10

12-health-care-stocks-moving-in-wednesdays-pre-market-session
12 Health Care Stocks Moving In Wednesday'...
02/12/2025 21:05:46

nkgen-biotech-receives-fda-fast-track-designation-for-troculeucel-in-treatment-of-moderate-alzheimers-disease
NKGen Biotech Receives FDA Fast Track Desi...
02/12/2025 13:10:05

nkgen-biotech-receives-nasdaq-non-compliance-notice-for-market-value-of-publicly-held-shares-below-15m-minimum-plans-to-monitor-and-explore-options-to-regain-compliance
NKGen Biotech Receives Nasdaq Non-Complian...
12/04/2024 21:32:49

nkgen-biotech-selected-as-stalking-horse-bidder-for-nkmax-nkgen-proposal-included-up-to-18m-in-committed-funding
NKGen Biotech Selected As Stalking Horse B...
12/02/2024 21:15:03

Upon closing, the transaction would secure global IP rights for NKGen.NKGen and its partners can begin to commercialize trocule...

nkgen-biotech-receives-notifications-from-nasdaq-related-to-delayed-quarterly-report-and-decision-of-the-nasdaq-hearings-panel-the-company-does-not-intend-to-appeal-the-decision-letter-at-this-time-and-intends-to-deliver-an-updated-plan-of-compliance-to-the-panel-no-later-than-january-7-2025
NKGen Biotech Receives Notifications From ...
11/26/2024 21:23:53

NKGen Biotech, Inc. (NASDAQ:NKGN) ("NKGen" or the "Company"), today announced it received a notice (the "No...

12-health-care-stocks-moving-in-mondays-pre-market-session
12 Health Care Stocks Moving In Monday's P...
11/25/2024 21:05:40

nkgen-biotech-presents-phase-12a-data-on-troculeucel-in-alzheimers-disease-at-ctad-conference-showing-biomarker-reductions-and-cognitive-improvement-highest-dose-demonstrates-safety-with-potential-to-delay-dementia
NKGen Biotech Presents Phase 1/2a Data On ...
10/29/2024 12:07:28

why-spirit-airlines-shares-are-trading-higher-by-around-44-here-are-20-stocks-moving-premarket
Why Spirit Airlines Shares Are Trading Hig...
10/21/2024 11:03:25

12-health-care-stocks-moving-in-fridays-intraday-session
12 Health Care Stocks Moving In Friday's I...
10/18/2024 16:30:58

dow-falls-over-100-points-netflix-posts-upbeat-results
Dow Falls Over 100 Points; Netflix Posts U...
10/18/2024 14:27:15

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION